Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 17, 2013

Burch v. Ariad Pharmaceuticals, Inc. et al

Track this case

Case Number:

1:13-cv-12626

Court:

Massachusetts

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

William G. Young

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 17, 2013

    Ariad Investor Says Drug Side Effects Led To Stock Drop

    An investor hit Ariad Pharmaceuticals Inc. with a putative class action in Massachusetts federal court on Thursday, alleging the oncology company made false statements about its leukemia drug Iclusig then disclosed the dangerous side effects later, causing Ariad's stock to plummet nearly 66 percent.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login